Engineered Tet repressors with recognition specificity for the tetO-4C5G operator variant

Area of Science:

• Molecular Biology
• Protein Engineering
• Synthetic Biology

Background:

• Tetracycline repressor (TetR) is a transcriptional regulator controlling gene expression.
• Modifying TetR's DNA binding specificity is crucial for developing advanced genetic tools.

Purpose of the Study:

• To engineer TetR variants with novel DNA recognition capabilities.
• To explore TetR's potential in sophisticated multigene regulation systems.

Main Methods:

• Doped oligonucleotide mutagenesis was used to create TetR variants.
• Amino acid substitutions at positions 36, 37, 39, and 42 were investigated.
• TetR variants were tested for binding to modified tet operator sequences (tetO-4C5G).

Main Results:

• Specific TetR variants, notably E37A P39K, demonstrated binding to the tetO-4C5G operator.
• The E37A mutation enhanced TetR affinity for modified operators.
• Lys39 was identified as critical for specific interaction with tetO-4C5G base pairs.
• Engineered TetR variants with dual specificities showed expression level-dependent binding accuracy.

Conclusions:

• Novel TetR variants with engineered DNA recognition specificity were successfully created.
• TetR variants offer precise control over gene expression, essential for complex genetic circuits.
• Expression levels significantly influence in vivo DNA binding specificity of transcription factors.